Skip to content
Biotron Limited
  • Home
  • About Us
    • Board of Directors
    • Management Team
  • Technology
    • Clinical programs
    • Non-clinical programs
    • Intellectual property
  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
  • Investor Centre
    • ASX Announcements
    • Financial Reports
      • Annual
      • Half-year
      • Quarterly
    • Corporate Directory
    • Shareholder services
    • Options Exercise Instructions
    • Top 40 Shareholders/Options
    • Corporate Governance
    • Corporate Presentations
  • Contacts

Scientific Presentations

  • 30 Nov 2018

    Peer Validation of Phase 2 HIV-1 Trial Data

  • 28 Nov 2018

    Presentation to HIV DART and Emerging Viruses Conference 2018

  • 23 Jul 2014

    Presentation to International AIDS Conference 2014

  • 12 Dec 2013

    Presentation to HepDART 2013

  • 5 Dec 2013

    Presentation to International HIV Persistence Meeting

  • 6 Nov 2013

    Presentation to International Liver Conference

  • 1 Jul 2013

    Presentation of HIV International AIDS Society Conference 2013

  • 1 May 2013

    Poster presented at European Liver Conference

  • 16 Nov 2012

    Presentation of BIT225 Hepatitis C Virus 48-week data at AASLD conference, Boston MA

 

News

  • News/Resources
    • Newsletters
    • In the news
    • Scientific Presentations
    • Scientific Publications
    • Subscribe
© Biotron Limited 2016       ABN 60 086 399 144        Site updated 20 February 2019        Legal Notices and Privacy